Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin dose variability in children
2008-005395-27Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of warfarin in Fetal warfarin syndrome (FWS), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoints: Effect of pharmacogenetic and environmental factors on inter-individual variability in response to warfarin, Vitamin K status and warfarin dose variability and 1 more. Started Apr 2009; status: completed.
02
Drugs
warfarin
03
Conditions
Fetal warfarin syndrome (FWS)
Beyond the preview
Go deeper on 2008-005395-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005395-27.